ASX:UBI (Australia)
Â
Shs Chess Depository Interests US Prohibited repr 1 sh
A$
0.064
-0.0010 (-1.54%)
Apr 7
Warning! GuruFocus detected
4 Severe warning signs
with UBI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Universal Biosensors Inc
NAICS : 339112
SIC : 3841
ISIN : AU000000UBI2
Share Class Description:
ASX:UBI: Shs Chess Depository Interests US Prohibited repr 1 shDescription
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.13 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -5.72 | |||||
| Beneish M-Score | -3.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.3 | |||||
| 3-Year EBITDA Growth Rate | -3.6 | |||||
| 3-Year EPS without NRI Growth Rate | 6.9 | |||||
| 3-Year FCF Growth Rate | 7.3 | |||||
| 3-Year Book Growth Rate | -27.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.43 | |||||
| 9-Day RSI | 19.94 | |||||
| 14-Day RSI | 26.4 | |||||
| 3-1 Month Momentum % | -28 | |||||
| 6-1 Month Momentum % | -52 | |||||
| 12-1 Month Momentum % | -64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.96 | |||||
| Quick Ratio | 2.76 | |||||
| Cash Ratio | 1.83 | |||||
| Days Inventory | 841.48 | |||||
| Days Sales Outstanding | 98.45 | |||||
| Days Payable | 112.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.8 | |||||
| Shareholder Yield % | -57.03 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.69 | |||||
| Operating Margin % | -234.93 | |||||
| Net Margin % | -226.59 | |||||
| FCF Margin % | -202.31 | |||||
| ROE % | -70.61 | |||||
| ROA % | -48.81 | |||||
| ROIC % | -94.14 | |||||
| 3-Year ROIIC % | 34.96 | |||||
| ROC (Joel Greenblatt) % | -118.75 | |||||
| ROCE % | -58.48 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 8.82 | |||||
| PS Ratio | 2.83 | |||||
| PB Ratio | 1.12 | |||||
| Price-to-Tangible-Book | 1.07 | |||||
| EV-to-EBIT | -1.02 | |||||
| EV-to-Forward-EBIT | -7.26 | |||||
| EV-to-EBITDA | -1.09 | |||||
| EV-to-Forward-EBITDA | -24.19 | |||||
| EV-to-Revenue | 2.31 | |||||
| EV-to-Forward-Revenue | 1.34 | |||||
| EV-to-FCF | -1.17 | |||||
| Price-to-GF-Value | 0.32 | |||||
| Price-to-Median-PS-Value | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 2.13 | |||||
| Earnings Yield (Greenblatt) % | -98.12 | |||||
| FCF Yield % | -66.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Universal Biosensors Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 6.284 | ||
| EPS (TTM) (A$) | -0.05 | ||
| Beta | 0.89 | ||
| 3-Year Sharpe Ratio | -1.62 | ||
| 3-Year Sortino Ratio | -1.71 | ||
| Volatility % | 39.96 | ||
| 14-Day RSI | 26.4 | ||
| 14-Day ATR (A$) | 0.001384 | ||
| 20-Day SMA (A$) | 0.0698 | ||
| 12-1 Month Momentum % | -64 | ||
| 52-Week Range (A$) | 0.064 - 0.205 | ||
| Shares Outstanding (Mil) | 298.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Universal Biosensors Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Universal Biosensors Inc Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Universal Biosensors Inc Frequently Asked Questions
What is Universal Biosensors Inc(ASX:UBI)'s stock price today?
The current price of ASX:UBI is A$0.06. The 52 week high of ASX:UBI is A$0.21 and 52 week low is A$0.06.
When is next earnings date of Universal Biosensors Inc(ASX:UBI)?
The next earnings date of Universal Biosensors Inc(ASX:UBI) is .
Does Universal Biosensors Inc(ASX:UBI) pay dividends? If so, how much?
Universal Biosensors Inc(ASX:UBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers